VAERS reports by lot

Moderna COVID-19 lot 016J21-2A: VAERS reports

269 VAERS reports list lot 016J21-2A as a Moderna COVID-19 vaccine, received between 2022-01-07 and 2024-04-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
269
Reports
7%
Marked serious
2
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)9321%
Neurological7417%
Cardiac / Cardiovascular4911%
Respiratory409%
Musculoskeletal348%
Injection-site / Local reaction348%
Allergic / Anaphylactic327%
Gastrointestinal327%
Dermatological (non-injection-site)327%
Psychiatric / Neuropsychiatric123%
Thrombotic / Hematological72%
Autoimmune / Immune-mediated31%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Nebraska69
Virginia36
California31
Alabama26
Tennessee9
South Carolina9
New York8
Texas6
Massachusetts6
Washington6
Michigan6
Illinois5

Reports by month received

2022-0143
2022-0233
2022-0318
2022-0460
2022-0584
2022-0611
2022-075
2022-081
2022-103
2022-111
2022-122
2023-012
2023-042
2023-061
2023-082
2024-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.